Evidence map›Paper›PMID 39695074›Full record

ArticleCell death & disease2024

Downregulation of tRNA methyltransferase FTSJ1 by PM2.5 promotes glycolysis and malignancy of NSCLC via facilitating PGK1 expression and translation.

Yiling Wang, Yuxin Wen, Qianqian Chen, Yongyi Huang, Duanyang Zhou, Wenhan Yang, Lin Yang, Juan Xiong, Kaiping Gao, Liyuan Sun and 1 more

Abstract read
In one paragraph

Article in Cell death & disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yiling Wang *School of Public Health, Shenzhen University Medical School, 1066 Xueyuan Ave, Shenzhen, 518055, China.
Yuxin Wen *Department of Thoracic Surgery, The People's Hospital of Shenzhen, 1017 North Dongmen Road, Shenzhen, 518020, China.
Qianqian Chen *School of Public Health, Shenzhen University Medical School, 1066 Xueyuan Ave, Shenzhen, 518055, China.
Yongyi HuangSchool of Public Health, Shenzhen University Medical School, 1066 Xueyuan Ave, Shenzhen, 518055, China.
Duanyang ZhouSchool of Public Health, Shenzhen University Medical School, 1066 Xueyuan Ave, Shenzhen, 518055, China.
Wenhan YangSchool of Public Health, Shenzhen University Medical School, 1066 Xueyuan Ave, Shenzhen, 518055, China.
Lin YangDepartment of Thoracic Surgery, The People's Hospital of Shenzhen, 1017 North Dongmen Road, Shenzhen, 518020, China.
Juan XiongSchool of Public Health, Shenzhen University Medical School, 1066 Xueyuan Ave, Shenzhen, 518055, China.
Kaiping GaoSchool of Public Health, Shenzhen University Medical School, 1066 Xueyuan Ave, Shenzhen, 518055, China. gao_kp@szu.edu.cn.ORCID 0000-0003-3418-6731
Liyuan SunSchool of Nursing, Shenzhen University Medical School, 1066 Xueyuan Ave, Shenzhen, 518055, China. liyuandali@szu.edu.cn.
Rihong ZhaiSchool of Public Health, Shenzhen University Medical School, 1066 Xueyuan Ave, Shenzhen, 518055, China. rzhai@szu.edu.cn.ORCID 0000-0003-0631-4134

Funding

National Natural Science Foundation of China (National Science Foundation of China) 41977372Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) 2022A1515012033, 2024A1515012760Shenzhen Science and Technology Innovation Commission 20231121155815200Shenzhen Science and Technology Innovation Commission JCYJ20190806154210829Shenzhen Science and Technology Innovation Commission JCYJ20220531102612029
6 · The paper itself

Abstract

Fine particulate matter (PM2.5) exposure has been associated with increased incidence and mortality of lung cancer. However, the molecular mechanisms underlying PM2.5 carcinogenicity remain incompletely understood. Here, we identified that PM2.5 suppressed the expression of tRNA methyltransferase FTSJ1 and Am modification level of tRNA in vitro and in vivo. FTSJ1 downregulation enhanced glycolytic metabolism of non-small cell lung cancer (NSCLC) cells, as indicated by increased levels of lactate, pyruvate, and extracellular acidification rate (ECAR). Whereas treatment with glycolytic inhibitor 2-DG reversed this effect. In contrast, upregulation of FTSJ1 significantly suppressed glycolysis of NSCLC cells. Mechanistically, the silencing of FTSJ1 increased NSCLC cell proliferation and glycolysis through enhancing the expression and translation of PGK1. In human NSCLC tumor samples, FTSJ1 expression was negatively correlated with PGK1 expression level and the SUVmax value of PET/CT scan. In summary, our work reveals a previously unrecognized function of PM2.5-downregulated FTSJ1 on PGK1-mediated glycolysis in NSCLC, suggesting that targeted upregulation of FTSJ1 may represent a potential therapeutic strategy for NSCLC.

Indexed as

Carcinoma, Non-Small-Cell LungDown-RegulationGlycolysisLung NeoplasmsMethyltransferasesPhosphoglycerate KinaseAnimalsCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticHumansMiceMice, Inbred BALB CMice, NudeParticulate MatterProtein BiosynthesisMethyltransferasesParticulate MatterPGK1 protein, humanPhosphoglycerate Kinase

Identifiers

PMID39695074
PMCPMC11655989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.